Shattuck Labs, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
Shattuck Labs, Inc. (STTK) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $200.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-08-11
- Shattuck Labs, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2026-06-30 was $0.00.
- Shattuck Labs, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2026-03-31 was $200.00K.
- Shattuck Labs, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-12-31 was $0.00.
- Shattuck Labs, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-09-30 was $0.00.
- Shattuck Labs, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Shattuck Labs, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $1.70M, a 325.00% increase from fiscal 2023.
- Shattuck Labs, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $400.00K, a 300.00% increase from fiscal 2022.
- Shattuck Labs, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $100.00K, a 99.15% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $200.00K 10-Q · filed 2026-08-11 | $200.00K derived: sum of 3 quarters · filed 2026-08-11 | $200.00K derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | $200.00K 10-Q · filed 2026-05-07 | $200.00K derived: sum of 2 quarters · filed 2026-05-07 | $200.00K derived: sum of 3 quarters · filed 2026-05-07 | $200.00K derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $0.00 derived: sum of 2 quarters · filed 2026-03-05 | $0.00 derived: sum of 3 quarters · filed 2026-08-11 | $0.00 10-K · filed 2026-03-05 | ||||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2026-08-11 | $0.00 10-Q · filed 2025-11-06 | -$200.00K derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $0.00 10-Q · filed 2026-08-11 | -$200.00K derived: sum of 3 quarters · filed 2026-08-11 | -$200.00K derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-07 | -$200.00K derived: sum of 2 quarters · filed 2026-05-07 | -$200.00K derived: sum of 3 quarters · filed 2026-05-07 | $1.10M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | -$200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$200.00K derived: sum of 2 quarters · filed 2026-03-05 | $1.10M derived: sum of 3 quarters · filed 2026-03-05 | $1.70M 10-K · filed 2026-03-05 | ||||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.30M derived: sum of 2 quarters · filed 2025-11-06 | $1.90M 10-Q · filed 2025-11-06 | $2.30M derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | $1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $1.90M 10-Q · filed 2025-08-14 | $2.30M derived: sum of 3 quarters · filed 2025-08-14 | $2.30M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $600.00K 10-Q · filed 2025-05-01 | $1.00M derived: sum of 2 quarters · filed 2025-05-01 | $1.00M derived: sum of 3 quarters · filed 2025-05-01 | $900.00K derived: sum of 4 quarters · filed 2025-05-01 | ||||
| 2023-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $400.00K derived: sum of 2 quarters · filed 2025-03-27 | $300.00K derived: sum of 3 quarters · filed 2025-03-27 | $400.00K 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$100.00K derived: sum of 2 quarters · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | $0.00 derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | -$100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $0.00 10-Q · filed 2024-08-01 | $0.00 derived: sum of 3 quarters · filed 2024-08-01 | $0.00 derived: sum of 4 quarters · filed 2024-08-01 | ||||
| 2023-03-31 | $100.00K 10-Q · filed 2024-05-02 | $100.00K derived: sum of 2 quarters · filed 2024-05-02 | $100.00K derived: sum of 3 quarters · filed 2024-05-02 | $100.00K derived: sum of 4 quarters · filed 2024-05-02 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $0.00 derived: sum of 2 quarters · filed 2024-02-29 | $0.00 derived: sum of 3 quarters · filed 2024-02-29 | $100.00K 10-K · filed 2024-02-29 | ||||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $100.00K 10-Q · filed 2023-11-09 | $1.70M 10-Q · filed 2022-11-09 | -$15.30M derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $100.00K 10-Q · filed 2023-08-10 | $3.90M 10-Q · filed 2022-08-11 | -$15.30M derived: sum of 3 quarters · filed 2023-08-10 | -$24.30M derived: sum of 4 quarters · filed 2023-08-10 | |||
| 2022-03-31 | $100.00K 10-Q · filed 2023-05-09 | $4.10M 10-Q · filed 2022-05-12 | -$15.30M derived: sum of 2 quarters · filed 2023-05-09 | -$24.30M derived: sum of 3 quarters · filed 2023-05-09 | -$16.20M derived: sum of 4 quarters · filed 2023-05-09 | |||
| 2021-12-31 | -$15.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$24.40M derived: sum of 2 quarters · filed 2023-02-23 | -$16.30M derived: sum of 3 quarters · filed 2023-02-23 | $11.80M 10-K · filed 2023-02-23 | $10.80M 10-K · filed 2022-03-15 | |||
| 2021-09-30 | -$9.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$900.00K derived: sum of 2 quarters · filed 2022-11-09 | $27.20M 10-Q · filed 2022-11-09 | |||||
| 2021-06-30 | $8.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $36.20M 10-Q · filed 2022-08-11 | ||||||
| 2021-03-31 | $28.10M 10-Q · filed 2022-05-12 | |||||||
| 2020-12-31 | $49.70M 10-K · filed 2022-03-15 | |||||||
| 2019-12-31 | $400.00K 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |